{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:15:31Z","timestamp":1793970931676,"version":"4.8.0"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI133127"],"award-info":[{"award-number":["U19AI133127"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL127413"],"award-info":[{"award-number":["R01HL127413"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R33AI094519"],"award-info":[{"award-number":["R33AI094519"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB020147"],"award-info":[{"award-number":["R01EB020147"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johns Hopkins University Center for AIDS Research","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.addr.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T12:28:35Z","timestamp":1445257715000},"page":"28-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4419,"special_numbering":"PA","title":["PEGylation as a strategy for improving nanoparticle-based drug and gene delivery"],"prefix":"10.1016","volume":"99","author":[{"given":"Jung Soo","family":"Suk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2015.09.012_bb0005","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb0010","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1): products on the market","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2015.09.012_bb0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jps.2600721213","article-title":"Acrylic microspheres in vivo IX: blood elimination kinetics and organ distribution of microparticles with different surface characteristics","volume":"72","author":"Arturson","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0142-9612(93)90004-L","article-title":"Surface modification of nanoparticles by PEO\/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats","volume":"14","author":"Tan","year":"1993","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.RVI.0000175324.63304.25","article-title":"Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time","volume":"16","author":"Ahmed","year":"2005","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.addr.2015.09.012_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2015.09.012_bb0040","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","article-title":"Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors","volume":"11","author":"Laginha","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jemt.20408","article-title":"Contribution of high-resolution correlative imaging techniques in the study of the liver sieve in three-dimensions","volume":"70","author":"Braet","year":"2007","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.addr.2015.09.012_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0060","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.biomaterials.2006.03.039","article-title":"Parameters influencing the stealthiness of colloidal drug delivery systems","volume":"27","author":"Vonarbourg","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.09.012_bb0070","first-page":"39","article-title":"Serum opsonins and liposomes: their interaction and opsonophagocytosis","volume":"9","author":"Patel","year":"1992","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2015.09.012_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0378-5173(99)00432-9","article-title":"Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption","volume":"196","author":"Gessner","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0939-6411(98)00038-1","article-title":"Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats","volume":"46","author":"Roser","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0927-7765(98)00045-9","article-title":"Interpretation of protein adsorption phenomena onto functional microspheres","volume":"12","author":"Yoon","year":"1998","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.addr.2015.09.012_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejpb.2010.11.010","article-title":"Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages","volume":"77","author":"Arnida","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0005-2736(95)00196-4","article-title":"Serum independent liposome uptake by mouse liver","volume":"1278","author":"Liu","year":"1996","journal-title":"Bba-Biomembranes"},{"key":"10.1016\/j.addr.2015.09.012_bb0100","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2015.09.012_bb0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nnano.2013.181","article-title":"Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology","volume":"8","author":"Tenzer","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0120","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.gt.3300683","article-title":"Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery","volume":"5","author":"Li","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0125","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/sj.gt.3301039","article-title":"Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs","volume":"6","author":"Bragonzi","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt0297-167","article-title":"Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery","volume":"15","author":"Liu","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0135","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2015.09.012_bb0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions, Wiley interdisciplinary reviews","volume":"7","author":"Yang","year":"2015","journal-title":"Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0145","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.09.012_bb0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2013.09.026","article-title":"Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice","volume":"172","author":"Stirland","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0155","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/bit.20562","article-title":"PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization","volume":"92","author":"Lee","year":"2005","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2015.09.012_bb0165","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0170","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.05.036","article-title":"State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines","volume":"187","author":"Dawidczyk","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0180","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-08-4242","article-title":"Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas","volume":"69","author":"von Maltzahn","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0185","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","article-title":"Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status","volume":"65","author":"van der Meel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2014.06.031","article-title":"Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood\u2013brain barrier using MRI-guided focused ultrasound","volume":"189","author":"Nance","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0195","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ultras.2004.01.089","article-title":"High-intensity focused ultrasound for the treatment of liver tumours","volume":"42","author":"Kennedy","year":"2004","journal-title":"Ultrasonics"},{"key":"10.1016\/j.addr.2015.09.012_bb0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2015.09.012_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2014.10.036","article-title":"Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers","volume":"38","author":"Miteva","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(91)80699-4","article-title":"Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo","volume":"284","author":"Mori","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"16","author":"Gref","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.addr.2015.09.012_bb0225","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbamem.2006.12.013","article-title":"Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding","volume":"1768","author":"Dos Santos","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2015.09.012_bb0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0235","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1021\/nn5061578","article-title":"Engineering poly(ethylene glycol) particles for improved biodistribution","volume":"9","author":"Cui","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb0240","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.biomaterials.2009.10.046","article-title":"The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0245","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/nl900031y","article-title":"Mediating tumor targeting efficiency of nanoparticles through design","volume":"9","author":"Perrault","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10611869909085493","article-title":"Interactions between a macrophage cell line (J774A1) and surface-modified poly (D, L-lactide) nanocapsules bearing poly(ethylene glycol)","volume":"7","author":"Mosqueira","year":"1999","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2015.09.012_bb0255","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1023\/A:1012248721523","article-title":"Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density","volume":"18","author":"Mosqueira","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jps.2600840420","article-title":"Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system","volume":"84","author":"Bazile","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb0270","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/mp400703d","article-title":"Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation","volume":"11","author":"Yang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0275","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1021\/nl103264u","article-title":"Sizing nanomatter in biological fluids by fluorescence single particle tracking","volume":"10","author":"Braeckmans","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0280","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2015.09.012_bb0285","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11095-006-9662-5","article-title":"Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors","volume":"23","author":"Khalid","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0295","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jp053760a","article-title":"Decorated rods: a \u201cbottom-up\u201d self-assembly of monomolecular DNA complexes","volume":"110","author":"DeRouchey","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.addr.2015.09.012_bb0300","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0142-9612(95)00322-3","article-title":"Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators","volume":"17","author":"Vittaz","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jbm.a.30056","article-title":"Polyethylene glycol-grafted polystyrene particles","volume":"70","author":"Meng","year":"2004","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2015.09.012_bb0310","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.1010013108","article-title":"Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles","volume":"108","author":"Merkel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0320","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1462-5822.2007.00981.x","article-title":"Macrophage complement receptors and pathogen clearance","volume":"9","author":"van Lookeren Campagne","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2015.09.012_bb0325","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1021\/la702310t","article-title":"Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action","volume":"24","author":"Unsworth","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2015.09.012_bb0330","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0335","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jbm.a.30711","article-title":"Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake","volume":"78","author":"Vonarbourg","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2015.09.012_bb0340","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0345","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/adma.201202932","article-title":"Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles","volume":"25","author":"Jiang","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2015.09.012_bb0350","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0355","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/bj20020590","article-title":"Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions","volume":"366","author":"Shi","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2015.09.012_bb0360","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1021\/acsnano.5b00147","article-title":"Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting","volume":"9","author":"Anselmo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb0365","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/mp800032f","article-title":"Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution","volume":"5","author":"Dobrovolskaia","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2478\/s11658-011-0033-9","article-title":"Influence of dendrimers on red blood cells","volume":"17","author":"Ziemba","year":"2012","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb0375","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0380","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.gt.3301705","article-title":"Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery","volume":"9","author":"Eliyahu","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.18433\/J3GK52","article-title":"Chondroitin sulfate capsule system for efficient and secure gene delivery","volume":"13","author":"Kurosaki","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb0390","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1021\/ma012060a","article-title":"Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers","volume":"35","author":"Petersen","year":"2002","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2015.09.012_bb0395","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1208\/s12248-009-9116-1","article-title":"PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression","volume":"11","author":"Qi","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2015.09.012_bb0400","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/bc025529v","article-title":"Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system","volume":"13","author":"Petersen","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb0405","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2015.09.012_bb0410","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2015.09.012_bb0415","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0420","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2015.09.012_bb0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000233512","article-title":"Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.addr.2015.09.012_bb0430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics3010001","article-title":"Anti-PEG IgM response against PEGylated liposomes in mice and rats","volume":"3","author":"Ichihara","year":"2010","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2015.09.012_bb0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0445","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0450","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.addr.2015.09.012_bb0455","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.imbio.2012.08.274","article-title":"Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon","volume":"218","author":"Shimizu","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.addr.2015.09.012_bb0460","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0465","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2007.11.009","article-title":"The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats","volume":"126","author":"Ishida","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0470","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0475","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2010.12.013","article-title":"Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA","volume":"151","author":"Tagami","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0485","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2012.08.030","article-title":"Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application","volume":"438","author":"Abu Lila","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0490","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0495","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2009.10.017","article-title":"CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes","volume":"142","author":"Tagami","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0500","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0505","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","article-title":"Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0510","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.04.006","article-title":"Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production","volume":"137","author":"Tagami","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0515","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1248\/bpb.b12-00276","article-title":"Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response","volume":"35","author":"Shimizu","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2015.09.012_bb0520","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/10717544.2014.885998","article-title":"Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection","volume":"22","author":"Xu","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2015.09.012_bb0525","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2012.11.016","article-title":"Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon","volume":"165","author":"Shiraishi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0530","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2005.01.008","article-title":"Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats","volume":"104","author":"Wang","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0535","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.06.004","article-title":"Particle size-dependent triggering of accelerated blood clearance phenomenon","volume":"362","author":"Koide","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0540","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molimm.2013.07.014","article-title":"Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins","volume":"57","author":"Saifer","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2015.09.012_bb0545","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bc200551b","article-title":"Role of the methoxy group in immune responses to mPEG-protein conjugates","volume":"23","author":"Sherman","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb0550","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s11095-009-9943-x","article-title":"Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles","volume":"26","author":"Ishihara","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0555","series-title":"PEGylated Protein Drugs: Basic Science and Clinical Applications, Birkh\u00e4user Basel","first-page":"147","article-title":"The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol)","author":"Armstrong","year":"2009"},{"key":"10.1016\/j.addr.2015.09.012_bb0560","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2015.09.012_bb0565","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.addr.2007.11.009","article-title":"Polymer\u2013drug conjugates: recent development in clinical oncology","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0570","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1016\/j.biomaterials.2007.07.046","article-title":"In vivo biological evaluation of high molecular weight hyperbranched polyglycerols","volume":"28","author":"Kainthan","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0575","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.1157","article-title":"Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley interdisciplinary reviews","volume":"4","author":"Amoozgar","year":"2012","journal-title":"Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb0580","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0585","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jps.23823","article-title":"Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery","volume":"103","author":"Abu Lila","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb0590","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1021\/bc800090v","article-title":"Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: biodistribution studies","volume":"19","author":"Kainthan","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0600","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb0605","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \u201cSelf\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.09.012_bb0610","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0615","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2015.09.012_bb0620","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0625","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2015.09.012_bb0630","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2004.06.001","article-title":"Real-time multiple-particle tracking: applications to drug and gene delivery","volume":"57","author":"Suh","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0635","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(99)00233-3","article-title":"Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces","volume":"65","author":"Huang","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0640","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1163\/156856297X00362","article-title":"Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter","volume":"8","author":"Sahlin","year":"1997","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.addr.2015.09.012_bb0645","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2005.10.011","article-title":"Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems","volume":"63","author":"Serra","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0650","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2015.09.012_bb0655","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0660","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.036","article-title":"In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery","volume":"156","author":"Cu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0665","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2015.09.012_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb0675","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2013","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.addr.2015.09.012_bb0680","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0685","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2013.05.035","article-title":"Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus","volume":"170","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0690","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-011-0048-9","article-title":"Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic\u2013glycolic acid)","volume":"2","author":"Yu","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0695","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nano.2014.09.019","article-title":"Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI)","volume":"11","author":"Yu","year":"2015","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb0700","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb0705","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0710","doi-asserted-by":"crossref","first-page":"e21547","DOI":"10.1371\/journal.pone.0021547","article-title":"Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2015.09.012_bb0715","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0720","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0725","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/nnm.12.129","article-title":"Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy","volume":"8","author":"Forier","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2015.09.012_bb0730","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0735","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2011.08.031","article-title":"Highly compacted DNA nanoparticles with low MW PEG coatings: In vitro, ex vivo and in vivo evaluation","volume":"157","author":"Boylan","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0740","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/mt.2011.160","article-title":"N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles","volume":"19","author":"Suk","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0745","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/anie.201208556","article-title":"Use of single-site functionalized peg-dendrons to prepare gene vectors that penetrate human mucus barriers","volume":"52","author":"Kim","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2015.09.012_bb0750","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2014.01.007","article-title":"Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier","volume":"178","author":"Suk","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0755","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0760","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051054","article-title":"Immobilization of pseudorabies virus in porcine tracheal respiratory mucus revealed by single particle tracking","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2015.09.012_bb0770","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0775","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1016\/j.biomaterials.2011.05.008","article-title":"Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus","volume":"32","author":"Lai","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0780","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10611860108997935","article-title":"Transport of nanoparticles across the rat nasal mucosa","volume":"9","author":"Brooking","year":"2001","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2015.09.012_bb0785","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1023\/A:1011922819926","article-title":"Stealth PLA-PEG nanoparticles as protein carriers for nasal administration","volume":"15","author":"Tobio","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0790","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","article-title":"Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density","volume":"98","author":"Vila","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0795","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0927-7765(99)00157-5","article-title":"The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration","volume":"18","author":"Tobio","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2015.09.012_bb0800","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2014.07.037","article-title":"\u2018Stealth\u2019 lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug","volume":"192","author":"Feeney","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0805","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1023\/A:1025714412337","article-title":"PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route","volume":"20","author":"Cheng","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0810","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0815","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/mp300649z","article-title":"Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles","volume":"10","author":"Yuan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0820","article-title":"In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration","author":"Inchaurraga","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0825","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0830","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/mp400087y","article-title":"Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues","volume":"10","author":"Ensign","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0835","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2013.09.016","article-title":"PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease","volume":"85","author":"Lautenschlager","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0840","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0509425103","article-title":"In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space","volume":"103","author":"Thorne","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0845","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb0850","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1021\/nn504210g","article-title":"Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration","volume":"8","author":"Nance","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb0855","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/adhm.201400800","article-title":"Highly PEGylated DNA nanoparticles provide uniform and widespread gene transfer in the brain","volume":"4","author":"Mastorakos","year":"2015","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.addr.2015.09.012_bb0860","series-title":"Biodegradable DNA nanoparticles that provide widespread gene delivery in the brain","author":"Mastorakos","year":"2015"},{"key":"10.1016\/j.addr.2015.09.012_bb0865","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"Jarvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0870","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1023\/A:1023290514575","article-title":"Influence of preparation conditions on acyclovir-loaded poly-d, l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability","volume":"20","author":"Giannavola","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0875","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2015.09.012_bb0880","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.4.3.11","article-title":"Topical ocular drug delivery to the back of the eye by mucus-penetrating particles","volume":"4","author":"Schopf","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.addr.2015.09.012_bb0885","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/mp500332m","article-title":"On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein","volume":"11","author":"Mun","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0890","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2007.05.004","article-title":"Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer","volume":"122","author":"Sanders","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0895","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2217\/nnm.12.202","article-title":"Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy","volume":"8","author":"Martens","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2015.09.012_bb0900","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0905","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/hum.2008.091","article-title":"Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses","volume":"19","author":"Weaver","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0910","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.09.005","article-title":"Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity","volume":"141","author":"van den Berg","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2009.09.032","article-title":"The use of PEGylated poly [2-(N, N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses","volume":"31","author":"Qiao","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0920","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/mp300190g","article-title":"Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration","volume":"9","author":"Zhan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0925","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1016\/j.biomaterials.2014.05.056","article-title":"Adenoviral vectors coated with cationic PEG derivatives for intravaginal vaccination against HIV-1","volume":"35","author":"Xie","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0930","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2015.09.012_bb0935","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.09.012_bb0940","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biomaterials.2014.11.054","article-title":"Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells","volume":"42","author":"Schneider","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb0945","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/mp900015y","article-title":"The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic","volume":"6","author":"Davis","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb0950","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0955","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb0960","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.2042-7158.2011.01376.x","article-title":"Cellular delivery of PEGylated PLGA nanoparticles","volume":"64","author":"Pamujula","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2015.09.012_bb0965","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jconrel.2006.11.028","article-title":"Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells","volume":"118","author":"Hu","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb0970","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.mt.6300365","article-title":"Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2015.09.012_bb0975","first-page":"735","article-title":"PEGylation of nanoparticles improves their cytoplasmic transport","volume":"2","author":"Suh","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2015.09.012_bb0980","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.09.012_bb0985","doi-asserted-by":"crossref","first-page":"17939","DOI":"10.1073\/pnas.1011368107","article-title":"Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy","volume":"107","author":"Kolishetti","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0990","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1073\/pnas.0711714105","article-title":"Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers","volume":"105","author":"Gu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb0995","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1073\/pnas.1011379108","article-title":"Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo","volume":"108","author":"Dhar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb1000","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1073\/pnas.0809154105","article-title":"Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA\u2013PEG nanoparticles","volume":"105","author":"Dhar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.09.012_bb1005","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/nl801736q","article-title":"Microfluidic platform for controlled synthesis of polymeric nanoparticles","volume":"8","author":"Karnik","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb1010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nnano.2012.168","article-title":"Microfluidic technologies for accelerating the clinical translation of nanoparticles","volume":"7","author":"Valencia","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2015.09.012_bb1020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/jcis.1995.1047","article-title":"Dynamic properties of poly(DL-lactide) and polyvinyl alcohol monolayers at the air\/water and dichloromethane\/water interfaces","volume":"169","author":"Boury","year":"1995","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2015.09.012_bb1025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(97)00106-5","article-title":"Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method","volume":"50","author":"Zambaux","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(01)00218-8","article-title":"PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats","volume":"71","author":"Li","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nano.2009.02.002","article-title":"PEGylated PLGA nanoparticles for the improved delivery of doxorubicin","volume":"5","author":"Park","year":"2009","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb1045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","article-title":"Pharmacokinetics of curcumin-loaded PLGA and PLGA\u2013PEG blend nanoparticles after oral administration in rats","volume":"101","author":"Khalil","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2015.09.012_bb1050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2007.07.038","article-title":"PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution","volume":"349","author":"Esmaeili","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb1055","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10856-009-3746-9","article-title":"In vitro macrophage uptake and in vivo biodistribution of PLA\u2013PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content","volume":"20","author":"Sheng","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.addr.2015.09.012_bb1060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2014.07.045","article-title":"Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol","volume":"192","author":"Yang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1065","series-title":"Liposomes: a Practical Approach","author":"Torchilin","year":"2003"},{"key":"10.1016\/j.addr.2015.09.012_bb1070","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.biomaterials.2007.01.003","article-title":"Nanoparticles of poly(lactide)\u2013tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery","volume":"28","author":"Lee","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2011.08.032","article-title":"A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles","volume":"157","author":"Mert","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1080","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1016\/j.biomaterials.2011.02.022","article-title":"Formulation of Docetaxel by folic acid-conjugated D-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy","volume":"32","author":"Mi","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-3659(02)00025-1","article-title":"Vitamin E TPGS used as emulsifier in the solvent evaporation\/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol (R))","volume":"80","author":"Mu","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biomaterials.2005.05.104","article-title":"Nanoparticles of poly(lactide)\/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release","volume":"27","author":"Zhang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1095","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1016\/j.biomaterials.2009.06.004","article-title":"Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications","volume":"30","author":"Lin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1100","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2008.12.013","article-title":"PLGA-lecithin-PEG core\u2013shell nanoparticles for controlled drug delivery","volume":"30","author":"Chan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1105","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1016\/j.biomaterials.2010.07.082","article-title":"PLGA\/polymeric liposome for targeted drug and gene co-delivery","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpb.2008.04.018","article-title":"Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin\u2013biotin technology: formulation development and in vitro anticancer activity","volume":"70","author":"Pulkkinen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.09.012_bb1120","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1021\/bc700483s","article-title":"Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity","volume":"19","author":"Kim","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2009.04.022","article-title":"Transepithelial transport of PEGylated Anionic poly(amidoamine) dendrimers: implications for oral drug delivery","volume":"138","author":"Sweet","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.09.012_bb1130","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1021\/bc9001689","article-title":"PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors","volume":"20","author":"Kim","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1135","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1021\/ja907069u","article-title":"Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50\u2013200nm","volume":"131","author":"Perrault","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2015.09.012_bb1140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","article-title":"Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time","volume":"386","author":"Uster","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2015.09.012_bb1145","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.bbamem.2012.06.019","article-title":"Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods","volume":"1818","author":"Nakamura","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.addr.2015.09.012_bb1150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2015.09.012_bb1155","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1039\/B606930D","article-title":"The chemical modification of liposome surfaces via a copper-mediated [3+2] azide-alkyne cycloaddition monitored by a colorimetric assay","author":"Cavalli","year":"2006","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2015.09.012_bb1160","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/c0cc00784f","article-title":"\u201cClickable\u201d, polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions","volume":"46","author":"Kumar","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2015.09.012_bb1165","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.biomaterials.2008.12.070","article-title":"Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan","volume":"30","author":"Sheng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1170","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1021\/ja983183m","article-title":"Nanometer gold clusters protected by surface-bound monolayers of thiolated poly(ethylene glycol) polymer electrolyte","volume":"120","author":"Wuelfing","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2015.09.012_bb1175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/nn2038516","article-title":"Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures","volume":"6","author":"Xia","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb1185","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/j.biomaterials.2011.04.078","article-title":"Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles","volume":"32","author":"Valencia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.09.012_bb1190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(03)00224-2","article-title":"Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles","volume":"259","author":"Avgoustakis","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.09.012_bb1195","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1021\/la011393y","article-title":"Poly(lactic acid)-poly(ethylene oxide) (PLA-PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona","volume":"18","author":"Heald","year":"2002","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2015.09.012_bb1200","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1021\/la049505j","article-title":"Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles","volume":"20","author":"Garcia-Fuentes","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2015.09.012_bb1205","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/nn100190v","article-title":"PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo","volume":"4","author":"Sun","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2015.09.012_bb1210","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1021\/ac1009832","article-title":"Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography\/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma","volume":"82","author":"Xu","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1215","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/ac902548m","article-title":"Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA","volume":"82","author":"Chuang","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1220","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/bc100067t","article-title":"Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies","volume":"21","author":"Su","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1225","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/bc050133f","article-title":"Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles","volume":"16","author":"Cheng","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.09.012_bb1230","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jpba.2007.05.006","article-title":"An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles","volume":"44","author":"Zabaleta","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.addr.2015.09.012_bb1235","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpba.2005.12.028","article-title":"Comparison of electrospray ionization mass spectrometry and evaporative light scattering detections for the determination of Poloxamer 188 in itraconazole injectable formulation","volume":"41","author":"Nair","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.addr.2015.09.012_bb1240","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1021\/ac062135e","article-title":"Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection","volume":"79","author":"Zillies","year":"2007","journal-title":"Anal. Chem."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15002173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15002173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:23:22Z","timestamp":1748643802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X15002173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":245,"alternative-id":["S0169409X15002173"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2015.09.012","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}